The Primary Tube Versus Trabeculectomy Study: Methodology of a Multicenter Randomized Clinical Trial Comparing Tube Shunt Surgery and Trabeculectomy with Mitomycin C.
Gedde Steven J, Chen Philip P, Heuer Dale K, Singh Kuldev, Wright Martha M, Feuer William J, Schiffman Joyce C, Shi Wei
AI Summary
This study compares tube shunts and trabeculectomy with mitomycin C for uncontrolled glaucoma, aiming to determine which primary surgery is more effective, providing crucial data for clinical practice.
Abstract
Purpose
To describe the methodology of the Primary Tube Versus Trabeculectomy (PTVT) Study.
Design
Multicenter randomized clinical trial.
Participants
Patients with medically uncontrolled glaucoma and no prior incisional ocular surgery.
Methods
Patients are being enrolled at 16 clinical centers and randomly assigned to treatment with a tube shunt (350-mm 2 Baerveldt glaucoma implant) or trabeculectomy with mitomycin C (0.4 mg/ml for 2 minutes).
Main outcome measures
The primary outcome measure is the rate of surgical failure, defined as intraocular pressure (IOP) more than 21 mmHg or reduced by less than 20% from baseline, IOP of 5 mmHg or less, reoperation for glaucoma, or loss of light perception vision. Secondary outcome measures include IOP, glaucoma medical therapy, visual acuity, visual fields, and surgical complications.
Conclusions
Practice patterns vary in the surgical management of glaucoma, and opinions differ among surgeons regarding the preferred primary operation for glaucoma. The PTVT Study will provide valuable information comparing the 2 most commonly performed glaucoma surgical procedures.
MeSH Terms
Shields Classification
Key Concepts3
The Primary Tube Versus Trabeculectomy (PTVT) Study is a multicenter randomized clinical trial comparing tube shunt surgery (350-mm 2 Baerveldt glaucoma implant) and trabeculectomy with mitomycin C (0.4 mg/ml for 2 minutes) in patients with medically uncontrolled glaucoma and no prior incisional ocular surgery.
The primary outcome measure for the Primary Tube Versus Trabeculectomy (PTVT) Study is the rate of surgical failure, defined as intraocular pressure (IOP) more than 21 mmHg or reduced by less than 20% from baseline, IOP of 5 mmHg or less, reoperation for glaucoma, or loss of light perception vision.
Secondary outcome measures for the Primary Tube Versus Trabeculectomy (PTVT) Study include IOP, glaucoma medical therapy, visual acuity, visual fields, and surgical complications.
Related Articles5
Deep sclerectomy with collagen implant in one eye compared with trabeculectomy in the other eye of the same patient.
Clinical TrialSuccess criteria and success rates in trabeculectomy with and without intraoperative antimetabolites using intensified postoperative care (IPC).
Observational StudyModified penetrating deep sclerectomy versus conventional trabeculectomy for the treatment of glaucoma: A 12-month randomized prospective study.
Randomized Controlled TrialIntravitreal bevacizumab improves trabeculectomy survival at 12 months: the bevacizumab in trabeculectomy study-a randomised clinical trial.
Randomized Controlled TrialHypotony Failure Criteria in Glaucoma Surgical Studies and Their Influence on Surgery Success.
Systematic ReviewIs this article assigned to the wrong chapter(s)? Let us know.